In this method, an engineered Ad vector containing the TRAIL coding gene was transferred into the MSCs (Ad-TRAIL-MSCs) then the Ad-TRAIL-MSCs were administered to mouse models of PDA. This evidence concerns the gene TNFSF10 and Patent ductus arteriosus.